Table 1.
Subgroup | 90-Day Mortality | 1-Year Mortality | ||||
---|---|---|---|---|---|---|
Procalcitonin | Usual Care | Difference (95% CI) | Procalcitonin | Usual Care | Difference (95% CI) | |
no./total no. (%) | percentage points | no./total no. (%) | percentage points | |||
CAP | 10/167 (6.0) | 8/161 (5.0) | 1.0 (−51.2 to 53.2) | 18/167 (10.8) | 21/161 (13.0) | −2.3 (−64.6 to 60.0) |
COPD | 13/265 (4.9) | 5/259 (1.9) | 3.0 (−38.0 to 43.9) | 25/265 (9.4) | 26/259 (10.0) | −0.6 (−53.7 to 52.4) |
Asthma | 2/310 (0.6) | 2/336 (0.6) | 0.0 (−25.9 to 26.0) | 8/310 (2.6) | 9/336 (2.7) | −0.1 (−37.1 to 36.9) |
Acute bronchitis | 3/208 (1.4) | 1/190 (0.5) | 0.9 (−31.3 to 33.1) | 3/208 (1.4) | 5/190 (2.6) | −1.2 (−40.3 to 37.9) |
Percentages are Kaplan–Meier estimates. A patient could have more than one final diagnosis. Data are from National Death Index query results received in December 2018. CAP denotes community-acquired pneumonia, and COPD chronic obstructive pulmonary disease.